Regulation And Legal
Strides Receives USFDA EIR for Bengaluru Facility
Strides Pharma received USFDA Establishment Inspection Report for its Bengaluru facility, closing May 2026 inspection.
USFDA classified inspection as Voluntary Action Indicated after company addressed
